News
New Practice Guideline Addresses Pharmacy Access to Buprenorphine
The and the began distributing a first-of-its-kind practice guideline to the nation’s 60,000 community pharmacists. It’s part of an ambitious effort to increase access to buprenorphine for opioid use disorder (OUD). The is designed to educate pharmacists about the importance of providing access to buprenorphine and help them navigate a complex set of regulatory and clinical barriers to access. It’s been endorsed by a wide array of professional societies and advocacy organizations, including the SA国际传媒, the , the , the , and .